World Renown BX Protocol™ for Lyme Disease... at NO COST?

​This study follows the company's previous 30-day “money back guarantee” study aimed at evaluating the effects of a money back guarantee on bolstering credibility and consumer confidence, as well as enrollment rates and refund request rates. The results of this study were impressive, revealing that the money back guarantee dramatically reduced the friction associated with investing in costly medical treatments without possessing a fair level of confidence that the treatment is viable. This study demonstrated less than a 2% drop out rate, making this approach mutually attractive for the organization and consumer alike.

Money Back Guarantee vs. Performance-Based Trial

​The objective of the current study is aimed at comparing enrollment rates between the two models. The advantage for the consumer is that they are not required to provide any “up front” cost at all, representing a legitimate “RISK-FREE” proposition. In this case, the company assumes maximum risk, but with the potential for maximum enrollments. Ironically, using this model, the consumer and not the company becomes the primary source for potential fraud. Accordingly, the Delta organization asserts that they will implement due diligence strategies for minimizing risk associated with patients enrolling in the trial without the financial capabilities to enroll in the full program after the 30-day trial has ended. Delta's full program consists of a one year medically supervised protocol managed online with doctor oversight 5 days a week. The program is also accompanied by a second year maintenance period. The cost of the full membership is $16,995.00 The value of the 30-day period is calculated at 1/12the cost of the one year membership.

“This approach is certainly putting your money where your mouth is,” says consumer advocate Stan Verner. “A performance trial of this nature would require tremendous confidence in your product or service. Unfortunately, it seems to be a foreign concept in western medicine that a company should get paid or reimbursed on the basis of treatment outcomes rather than the strength of their television advertising. I applaud the company and wish them well.”

Unconventional programs, such as the BX protocol, are routinely criticized by the orthodox medical community for a lack of reliable information regarding safety and effectiveness. The obvious paradox with this assertion is that pharmaceutical drugs account for the 5th leading cause of death in the United States and are erroneously classified by the FDA as “safe and effective”. Unfortunately, Big Pharma has a knack for casting doubt on common sense, however, many would argue that performance-based outcomes using non-toxic nutraceuticals are a step above the FDA's statistical notion of safety and effectiveness.

Performance-based models like the ones offered through the Delta organization are somewhat unprecedented. Imagine asking your doctor if you could try his preferred treatment for 30-days at no cost. Moreover, the Delta organization is including a full medical review, medical consult, 30-days of medical case management, in addition to the costly nutraceuticals. Their reliance on pure performance should go a long way in nullifying skepticism. And with a customer satisfaction rate of 96.4%, the organization’s confidence may be warranted. Only time will tell.​

Study Details

The enrollment group will be limited to 200 individuals. Each individual will be required to provide performance evaluations that will be posted on a public website for review.

Additionally, enrollees will require a referral from an integrative doctor or qualified Lyme-literate healthcare professional.

Please visit the following website for enrollment details.​ www.LymePerformanceStudy.com

Disinformation Campaign Against BX Protocol (Be Advised)

In 2013 a suppression of dissent campaign was launched against the BX Protocol. A professionally hired counter-intelligence security firm identified 2 pharmaceutical companies involved in the funding and a New York based media firm that was contracted with to manage the campaign. This action against the Bx Protocol includes a vast network of forums, websites, blogs, and physician and university groups, representing a formidable network of media resources.

 Attacks against the BX Protocol, its founders, affiliates, members, and associates include:

1. Deleting, modifying, misquoting, and fabricating information about the BX Protocol, its founders, affiliates, members, and associates.

2. Obstructing research with 3 separate universities.

3. Dissemination of rumors.

4. Posing as patients in forums, social media, or other internet venues.

5. Filing formal complaints with government agencies. (Making complaints is one of their key tactics McDermott et al., 2014).

​The New York media firm certainly has their work cut out for them when Delta offers a treatment with a complete money back guarantee or performance-based risk-free trial period. ​Delta has not lashed out against the falsehoods circulated by their foes, but they have not avoided the attacks either.

“At Delta Institute, we don't spend our time worrying about our adversaries.  We recognize that rebuttals and legal reviews, though indispensable to establishing the truth, do not result in winning over the consumer. "Winning" results from credibility and a relationship of trust, built on a foundation of integrity, loyalty, and performance. We will never intentionally break the trust of our members.”  (Dewayne Smith, Ph.D, Board of Governors) ​

For more details about attacks against the Bx Protocol visit:
www.bxprotocolforum.com